Embryonic stem cells cloned from adults

Experiment could rekindle enthusiasm for therapeutic cloning

Charity tests new kind of drug trial

Cancer Research joins forces with pharmaceutical companies

Reckitt Benckiser eyes pharma spin-off

Group’s figures bolster ‘capital markets solution’ for RBP unit

Reckitt Benckiser eyeing pharma spin-off

Company’s strategic review highlights sale as ‘strong option’

Roche drug success counteracted by franc

Swiss currency’s strength hits pharmaceutical group’s revenues

NHS chiefs expect deficits in 2015-16

Think-tank says services face cuts unless there is more funding

Diamond’s adventure with BancABC

Precious Ramotswe cautions Diamond in his African adventure

UK stem cell blood set for human trials

Scheme seen as viable for patient tests by late 2016

GSK denies systemic corruption problem

BBC report says Polish doctors bribed to promote asthma drug

GPs’ surgery hours to be extended

Government aims to relieve pressure on A&E departments

Race for hepatitis C drugs accelerates

Scramble for share of market expected to reach $20bn in sales

Criminal probe launched into Herbalife

DoJ and FBI investigating claims company is pyramid scheme

Big pharma: Storehouse of trouble

A raft of lawsuits and regulatory probes has given critics fresh ammunition

Investors cool on latest London listings

Sebelius to resign as US health secretary

Disastrous rollout of healthcare law came during her watch

England lagging in healthcare gains

Researchers link differences to levels of performance management

French probe alleged drug collusion

Roche and Novartis investigated over lucrative eye treatment

Scientists hit out at UK flu expenditure

Government accused of throwing away more than £600m

Price of hepatitis C drug attacked

WHO condemns $1,000-a-day price of Gilead Sciences’ treatment

Actos case floors Takeda and Eli Lilly

Case highlights temptation to conceal potential health risks

COMPANIES NEWS ON TWITTER

More FT Twitter accounts